Amgen Researchers Find Gene That Reduces Heart Attack Risk
Researchers at DeCode Genetics, an Icelandic unit of the biotechnology firm Amgen, have identified a new genetic variant that reduces the risk of heart disease and stroke by 34%.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Matthew Herper Source Type: news
More News: Biotechnology | Cardiology | Genetics | Heart | Heart Attack | Heart Disease | Iceland Health | Pharmaceuticals | Stroke